Sputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its...

"In the population, the effectiveness of the Sputnik V vaccine in relation to Omicron is 75%," Gintsburg said in the Rossiya Segodnya press...

Vaccines from Moderna, AstraZeneca, Pfizer and partner BioNTech retained activity against Omicron, but the antibody response was greatly re...

Gamaleya said it expects Sputnik V to provide a strong defence against severe disease and hospitalisation, as the drop in neutralising acti...

According to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested ...

Its net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...

With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the ...

New Delhi-based Panacea Biotech has a collaboration with Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund which is bac...

Shares of Panacea Biotec have delivered 190 per cent return in the last one year, soaring from Rs 141.5 to Rs 407.2. The counter has more t...

India is one of the countries that has approved the Sputnik V vaccine, and the country is set to receive 50 million doses of the vaccine fr...

Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investmen...

The social media campaign will focus on progress of Sputnik V clinical trials, production and mass vaccination in different countries, acco...

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in ...

The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from...

The world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...

Earlier, Deputy Prime Minister Tatyana Golikova announced that mass production of the vaccine developed by the Gamaleya National Research C...

"RDIF is cooperating with Indian partners to share the most advanced practices to combat coronavirus, we have been in touch through the who...